Raymond James Financial Services Advisors Inc. Acquires 23,138 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Raymond James Financial Services Advisors Inc. increased its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 109.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 44,300 shares of the company's stock after acquiring an additional 23,138 shares during the quarter. Raymond James Financial Services Advisors Inc.'s holdings in Acadia Healthcare were worth $3,445,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Headlands Technologies LLC acquired a new position in shares of Acadia Healthcare in the 3rd quarter worth approximately $25,000. Point72 Hong Kong Ltd acquired a new position in Acadia Healthcare in the first quarter worth $38,000. Belpointe Asset Management LLC increased its stake in Acadia Healthcare by 75.7% during the first quarter. Belpointe Asset Management LLC now owns 982 shares of the company's stock valued at $71,000 after purchasing an additional 423 shares during the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in shares of Acadia Healthcare during the third quarter worth $96,000. Finally, Bessemer Group Inc. bought a new position in shares of Acadia Healthcare in the 4th quarter worth about $170,000.

Insider Transactions at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the firm's stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares of the company's stock, valued at $3,934,258.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 2.80% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. TheStreet upgraded shares of Acadia Healthcare from a "c" rating to a "b-" rating in a research note on Monday, March 4th. Royal Bank of Canada restated an "outperform" rating and set a $94.00 price objective on shares of Acadia Healthcare in a research report on Monday, March 4th. TD Cowen increased their target price on Acadia Healthcare from $86.00 to $101.00 and gave the stock an "outperform" rating in a research report on Friday, March 1st. Stephens raised shares of Acadia Healthcare from an "equal weight" rating to an "overweight" rating and set a $92.00 price target for the company in a report on Friday, January 5th. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, March 5th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Acadia Healthcare has a consensus rating of "Hold" and a consensus target price of $91.22.

Acadia Healthcare Price Performance

Acadia Healthcare stock traded down $0.54 during trading hours on Monday, hitting $75.43. 322,686 shares of the company traded hands, compared to its average volume of 567,691. Acadia Healthcare Company, Inc. has a 1-year low of $66.49 and a 1-year high of $87.77. The firm's 50-day simple moving average is $80.85 and its two-hundred day simple moving average is $77.44. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, beating analysts' consensus estimates of $0.80 by $0.05. The business had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business's revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter last year, the business earned $0.70 earnings per share. On average, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.